- Suppression of hepatic steatosis in non-alcoholic steatohepatitis model by modified Xiaoyao San formula: Evidence, mechanisms and perspective
- Browse: 218 Download: 464 Issue Date: 2024-10-21
- Prevalence and risk factors associated with metabolic dysfunction-associated steatohepatitis in patients with Helicobacter pylori infection: A population-based study
- Browse: 204 Download: 469 Issue Date: 2024-10-21
- False occult hepatitis B infection with negative hepatitis B surface antigen while positive hepatitis B envelope antigen: A case report
- Browse: 170 Download: 528 Issue Date: 2024-10-21
- Chronic hepatitis B: Prevent, diagnose, and treat before the point of no return
- Browse: 197 Download: 369 Issue Date: 2024-10-21
- Bioactive constituents and action mechanism of Xiaoyao San for treatment of non-alcoholic fatty liver disease
- Browse: 174 Download: 456 Issue Date: 2024-10-21
- Calcineurin inhibitors-related posterior reversible encephalopathy syndrome in liver transplant recipients: Three case reports and review of literature
- Browse: 134 Download: 477 Issue Date: 2024-09-23
- Hepatic ectopic pregnancy with hemorrhage secondary diaphragmatic adhesion: A case report
- Browse: 158 Download: 477 Issue Date: 2024-09-23
- Immune remodulation in pediatric inherited metabolic liver diseases
- Browse: 145 Download: 427 Issue Date: 2024-09-23
- Contribution of extracellular vesicles to steatosis-related liver disease and their therapeutic potential
- Browse: 149 Download: 490 Issue Date: 2024-09-23
- Kick-start for metabolomics in liver disease
- Browse: 153 Download: 406 Issue Date: 2024-09-23
- Causal association between 731 immunocyte phenotypes and liver cirrhosis: A bidirectional two-sample mendelian randomization analysis
- Browse: 176 Download: 466 Issue Date: 2024-08-22
- Blood cell counts and nonalcoholic fatty liver disease: Evidence from Mendelian randomization analysis
- Browse: 217 Download: 498 Issue Date: 2024-08-22
- Successful treatment of acute liver failure due to Wilson’s disease: Serendipity or fortuity?
- Browse: 200 Download: 433 Issue Date: 2024-08-22
- Bridging the gap: Addressing disparities in hepatitis C screening, access to care, and treatment outcomes
- Browse: 177 Download: 320 Issue Date: 2024-08-22
- Rocahepevirus ratti: An underrecognised cause of acute hepatitis
- Browse: 148 Download: 355 Issue Date: 2024-08-22
- Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years
- Browse: 275 Download: 579 Issue Date: 2024-07-26
- Chronic hepatitis B virus infection in Eastern Ethiopia: Clinical characteristics and determinants of cirrhosis
- Browse: 291 Download: 644 Issue Date: 2024-07-26
- Predictive value of serum alanine aminotransferase for fatty liver associated with metabolic dysfunction
- Browse: 269 Download: 496 Issue Date: 2024-07-26
- Interleukin-mediated therapies in liver diseases and comorbidity effects
- Browse: 285 Download: 594 Issue Date: 2024-07-26
- Roles of transforming growth factor-β signaling in liver disease
- Browse: 322 Download: 500 Issue Date: 2024-07-26